Table 2 Timing, dosing, route of administration and technological supplies for peritoneal carcinomatosis assessment by ICG fluorescence
Author | Time (h before incision) | Dose | Route for ICG administration | Camera system |
|---|---|---|---|---|
Barabino [9] | 24 h | 0,25 mg/kg | Intravenous | Fluostick (Fluopics, Grenoble, France) |
Liberale [10] | 0 h (assessment after 5′-40′) | 0,25 mg/kg | Intravenous | Photodynamic Eye, PDE (Hamamatsu Photonics, Japan) |
Lieto [11] | 0 h (assessment after 20′ (10′-30′) | 0,25 mg/kg | Intravenous | Fluobeam (Fluoptics Imaging Inc, Cambridge, MA, USA), |
Satou [12] | 1–5 d (1 pts 24 d) | 0, 5 mg/kg | Intravenous | PDE (Hamamatsu Photonics, Hamamatsu, Japan) |
Tummers [13] | 0 h (assessment after median 37′, max 141′) | 20 mg | Intravenous | Mini-Fluorescence-Assisted Resection and Exploration (Mini-FLARE) |
Veys [14] | 0 h (assessment after 5′-360′, mean 60′) | 0, 25 mg/kg | Intravenous | Photodynamic Eye, PDE (Hamamatsu Photonics, Japan) |